Articles

A New Molecular Cervical Cancer Test Will Aid Accurate Diagnosis
Value Propositions, Value Peer-spectives
September 2012, Vol 3, No 6
Quest Diagnostics, the leading provider of diagnostic testing, has introduced a new laboratory test that identifies molecular changes to cervical cells that may signal increased risk for cervical cancer.
Read More

Page 282 of 330

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.